These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3907038)
1. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Salvatierra O; Melzer J; Potter D; Garovoy M; Vincenti F; Amend WJ; Husing R; Hopper S; Feduska NJ Transplantation; 1985 Dec; 40(6):654-9. PubMed ID: 3907038 [TBL] [Abstract][Full Text] [Related]
2. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244 [TBL] [Abstract][Full Text] [Related]
3. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863 [TBL] [Abstract][Full Text] [Related]
5. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation. Glass NR; Miller DT; Sollinger HW; Belzer FO Transplantation; 1985 Jun; 39(6):615-9. PubMed ID: 3890291 [TBL] [Abstract][Full Text] [Related]
6. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients. Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M Nephron; 1997; 75(1):20-4. PubMed ID: 9031265 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Salvatierra O; Amend W; Vincenti F; Potter D; Iwaki Y; Opelz G; Terasaki P; Duca R; Hanes D; Cochrum KC; Hopper S; Feduska NJ Transplant Proc; 1981 Mar; 13(1 Pt 1):142-9. PubMed ID: 6455788 [TBL] [Abstract][Full Text] [Related]
8. Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran. Colombe BW; Lou CD; Salvatierra O; Garovoy MR Transplantation; 1987 Oct; 44(4):509-15. PubMed ID: 3313837 [TBL] [Abstract][Full Text] [Related]
9. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens. Leivestad T; Albrechtsen D; Flatmark A; Thorsby E Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880 [TBL] [Abstract][Full Text] [Related]
10. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience. Satoh S; Sugimura J; Omori S; Seino K; Fujizuka I Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639 [TBL] [Abstract][Full Text] [Related]
13. Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions, and cyclosporine on outcome. Sanfilippo F; Thacker L; Vaughn WK Transplantation; 1990 Jan; 49(1):25-9. PubMed ID: 2301022 [TBL] [Abstract][Full Text] [Related]
14. [The effect of donor specific blood transfusion (DST) on graft survival--intermittent coverage of cyclophosphamide]. Kasai I; Kumano K; Iwamura M; Yoshida K; Mashimo S; Endo T; Saaki T; Koshiba K; Kikuo I; Uchida H Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):367-71. PubMed ID: 2359213 [TBL] [Abstract][Full Text] [Related]
15. Living donor transplants. Cecka JM Clin Transpl; 1995; ():363-77. PubMed ID: 8794280 [TBL] [Abstract][Full Text] [Related]
16. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients. Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103 [TBL] [Abstract][Full Text] [Related]
17. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants. Cecka JM Clin Transpl; 1997; ():1-14. PubMed ID: 9919387 [TBL] [Abstract][Full Text] [Related]
18. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251 [TBL] [Abstract][Full Text] [Related]
19. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens. Sakagami K; Saito S; Shiozaki S; Fujiwara T; Haisa M; Niguma T; Kusaka S; Uda M; Matsuno T; Takasu S Acta Med Okayama; 1992 Feb; 46(1):1-5. PubMed ID: 1561899 [TBL] [Abstract][Full Text] [Related]
20. [Effect of donor-specific blood transfusion on the outcome of kidney transplantation]. Jovicić-Pavlović S; Lezaić V; Simić S; Blagojević-Lazić R; Stolić I; Simonović R; Radivojević-Djokić D; Djukanović L Srp Arh Celok Lek; 2003; 131(11-12):449-53. PubMed ID: 15114786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]